A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This study is designed to provide safety and efficacy data to support the development of
CP-690,550 in patients with moderate to severe rheumatoid arthritis on background of
methotrexate.